CAS: 112665-43-7 - Seratrodast
Formula:C6H9N3O2
InChI:InChI=1S/C22H26O4/c1-14-15(2)22(26)20(16(3)21(14)25)18(17-10-6-4-7-11-17)12-8-5-9-13-19(23)24/h4,6-7,10-11,18H,5,8-9,12-13H2,1-3H3,(H,23,24)
InChI key:InChIKey=ZBVKEHDGYSLCCC-UHFFFAOYSA-N
SMILES:O=C(O)CCCCCC(C=1C=CC=CC1)C=2C(=O)C(=C(C(=O)C2C)C)C
- Synonyms:
- (+-)-2,4,5-Trimethyl-3,6-dioxo-zeta-phenyl-1,4-cyclohexadiene-1-heptanoic acid
- (+-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid
- (±)-2,4,5-Trimethyl-3,6-dioxo-ζ-phenyl-1,4-cyclohexadiene-1-heptanoic acid
- 7-(2,4,5-Trimethyl-3,6-Dioxocyclohexa-1,4-Dienyl)-7-Phenylheptanoic Acid
- 7-Phenyl-7-(2,4,5-Trimethyl-3,6-Dioxocyclohexa-1,4-Dien-1-Yl)Heptanoic Acid
- A 73001
- Aa-2414
- Abbott 73001
- Abt 001
- Benzeneheptanoic acid, zeta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+-)-
- See more synonyms
- Benzeneheptanoic acid, ζ-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-
- Bronica
- Ccris 8939
- Seratodrast
- Seratrodast [USAN:INN]
- Unii-4U58Jm421N
- methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate
- ζ-(2,4,5-Trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)benzeneheptanoic acid
Seratrodast
CAS:112665-43-7
Seratrodast (ABT-001), a TXA2 receptor blocker, treats asthma; first approved in Japan, 1997.
Formula:
C22H26O4
Purity:
99.12% - 99.54%
Color and Shape:
Pale Orange Solid
Molecular weight:
354.44
Ref: TM-T0212
10mg | 51.00 € | ||
25mg | 72.00 € | ||
50mg | 92.00 € | ||
100mg | 138.00 € | ||
200mg | 172.00 € | ||
500mg | 279.00 € | ||
1mL*10mM (DMSO) | 52.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: IN-DA007SPA
1g | 247.00 € | ||
5g | To inquire | ||
100mg | 80.00 € | ||
250mg | 129.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 7W-GP3536
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Seratrodast
CAS:112665-43-7
Formula:
C22H26O4
Purity:
>98.0%(T)(HPLC)
Color and Shape:
Light yellow to Brown powder to crystal
Molecular weight:
354.45
Ref: 3B-S0943
1g | 410.00 € | ||
100mg | 75.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 10-F463443
50mg | To inquire | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Wednesday 18 Dec 2024
Seratrodast - Bio-X ™
CAS:112665-43-7
Seratrodast is a thromboxane receptor antagonist that is used to treat asthma. However, this drug …
Formula:
C22H26O4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
354.44 g/mol
Ref: 3D-BS164397
10mg | 141.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
Seratrodast
CAS:112665-43-7
Thromboxane A2 antagonist; anti-asthmatic
Formula:
C22H26O4
Purity:
Min. 95%
Color and Shape:
Yellow Powder
Molecular weight:
354.44 g/mol
Ref: 3D-FS27814
1g | 320.00 € | ||
2g | 488.00 € | ||
5g | 1,612.00 € | ||
250mg | 140.00 € | ||
500mg | 198.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
Seratrodast
Controlled ProductCAS:112665-43-7
Applications Thromboxane A2-receptor antagonist. Antiasthmatic. References Hussein, Z., et al.: Clin. Pharmacol. Ther., 55, 441 …
Formula:
C22H26O4
Color and Shape:
Neat
Molecular weight:
354.44
Ref: TR-S263000
5mg | 80.00 € | ||
10mg | 89.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025